North America Porcine Vaccine Market Size, Share, Growth, Trends, and Forecast 2016 - 2024
North America Porcine Vaccine Market: Scope of the Report
This
report on the porcine vaccine market analyzes the current and future
scenario of the North America market. Increase in disease indication
among swine, technological advancement of RNA strand methodology, and
cultivation of pig for growth in standard of living is accounted to
form growth in porcine vaccine segment. Increase trading facilities
of live hogs/pigs, demand of pork meat and innovation through
clinical research activities are some of the drivers expected to
drive the North America porcine vaccine market during the forecast
period.
The
North America porcine vaccine market report comprises an elaborate
executive summary, which includes market snapshot that provides
information about various segments. It also provides information and
data analysis of the country’s market with respect to the segments
based on disease indication, technology, end-user, and country. A
detailed qualitative analysis of drivers and restraints, and
opportunities has been provided in the market overview section.
Additionally, the section comprises Porters Five Forces Analysis to
help understand the competitive landscape in the market. This section
also provides market attractiveness analysis in terms of country and
market share analysis by key players, thus presenting a thorough
analysis of the overall competitive scenario in the North America
porcine vaccine market.
North
America Porcine Vaccine Market: Segmentation
Based
on disease indication, the market has been segmented into diarrhoea,
swine influenza, porcine reproductive and respiratory virus (PRRSV),
porcine circovirus associated disease (PCVAD) and others. Diarrhoea
is the most widely spread disease across the North America; porcine
epidemic diarrhea virus (PEDV) hit the United States in 2013 and
spread to Canada in 2014 which infected piglets and has 80%-100%
mortality rate. The market segments have been analyzed based on
available approved products, cost-effectiveness, and preference from
veterans for treating the swine with various disease indications. The
market size and forecast for each of these segments have been
provided for the period from 2014 to 2024, along with their
respective CAGRs for the forecast period from 2016 to 2024,
considering 2015 as the base year.
Based
on technology, the North America porcine vaccine market has been
segmented into inactivated vaccines, live attenuated vaccines, toxoid
vaccines, recombinant vaccines, conjugate vaccines, and DNA vaccines.
The market segments have been extensively analyzed based on increase
in demand for disease treatment such as PEDv, PRRSv, and PCVAD.
Demand of disease free pork meat, and increasing awareness for
treating the cultivated pigs are driving the market share of
technological segment. Different types of end-user utilize porcine
vaccines to treat swine diseases either. Under the end-user segment,
hog/pig production farms plays a major role followed by veterinary
hospitals. The market size and forecast in terms of US$ Mn for each
segment have been provided for the period from 2014 to 2024. The
report also provides the compound annual growth rate (CAGR %) for
each market segment for the forecast period from 2016 to 2024,
considering 2015 as the base year.
View
Report @
http://www.marketresearchreports.biz/analysis/901388
North
America Porcine Vaccine Market: Geographical and Competitive Dynamics
Geographically,
the North America porcine vaccine market has been categorized into
key countries: North America (the U.S. and Canada). The market size
and forecast for each of these regions and the mentioned countries
have been provided for the period from 2014 to 2024, along with their
respective CAGRs for the forecast period from 2016 to 2024,
considering 2015 as the base year.
The
report also profiles major players in the North America porcine
vaccine market based on various attributes such as company overview,
financial overview, product portfolio, business strategies, SWOT
analysis, and recent developments. Major players profiled in this
report include Bayer AG., Bimeda Animal Health, Boehringer Ingelheim
GmbH, Ceva Santé Animale, Elanco (Eli Lilly and Company), Merck &
Co., Inc., Merial (Sanofi), Vetoquinol, Zoetis Inc. and others.
Get
Sample Copy of this report @
http://www.marketresearchreports.biz/sample/sample/901388
The
North America porcine vaccine market has been segmented as follows:
North
America Porcine Vaccine Market, by Disease Indication
Diarrhoea
Swine Influenza
Arthritis
Bordatella Rhinitis
Porcine Reproductive and Respiratory
Virus (PRRSV)
Porcine Circovirus Associated Disease
(PCVAD)
Others
North
America Porcine Vaccine Market, by Technology
Inactivated Vaccines
Live Attenuated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines
DNA Vaccines
North
America Porcine Vaccine Market, by End-user
Veterinary Hospitals
Hog/Pig Production Farm
North
America Porcine Vaccine Market, by Country
North America
U.S.
Canada
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research
Methodology
3. Executive Summary : North
America Porcine Vaccine Market
4. Market Overview
4.1. Introduction
4.1.1. Disease Indication
Definition
4.1.2. Industry Evolution /
Developments
4.2. Overview
4.3. Key Market Indicators
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunity
4.5. North America Porcine Vaccine
Market Analysis and Forecasts, 2014–2024
4.6. Porter’s Five Force
Analysis
4.7.Regulations of Veterinary
Vaccine in North America
5. North America Porcine Vaccine
Market Analysis and Forecasts, By Disease Indication
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Key Trends
5.4. Market Value Share Analysis
Forecast By Disease Indication , 2014–2024
5.4.1. Diarrhoea
5.4.2. Swine Influenza
5.4.3. Arthritis
5.4.4. Bordatella Rhinitis
5.4.5. Porcine Reproductive and
Respiratory Virus (PRRSV)
5.4.6. Porcine Circovirus
Associated Disease (PCVAD)
5.4.7. Others
5.5. Disease Indication
Comparison Matrix
5.6. Market Attractiveness By
Disease Indication
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
Comments
Post a Comment